Standard BioTools Inc. Gain (Loss) Related to Litigation Settlement
Standard BioTools Inc. (LAB) reported Gain (Loss) Related to Litigation Settlement of $0 for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2016-11-09
- 2016-09-30: Gain (Loss) Related to Litigation Settlement 9 month $0.00.
- 2015-09-30: Gain (Loss) Related to Litigation Settlement 9 month $3.99M.
- 2014-09-30: Gain (Loss) Related to Litigation Settlement 9 month $0.00.
- 2013-09-30: Gain (Loss) Related to Litigation Settlement 9 month $600.00K.
| Period end | Gain (Loss) Related to Litigation Settlement 9 month |
|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 |
| 2015-09-30 | $3.99M 10-Q · filed 2016-11-09 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-09 |
| 2013-09-30 | $600.00K 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |